Sports Medicine
ISAKOS: Better quality & quantity of repair tissue with BST-CarGel® in cartilage lesions
80 patients with focal cartilage lesions were randomized to receive either BST-CarGel® + microfracture treatment or microfracture-only treatment. Results indicated an increase in the quality and quantity of the cartilage repair tissue (assessed using MRI and osteochondral biopsies) at 12 months post-treatment. There was no difference in clinical outcomes such as pain, stiffness and function (assessed using the WOMAC score) between groups.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
